logo

Evofem Biosciences Inc. (EVFM)



Trade EVFM now with
  Date
  Headline
3/4/2021 4:05:41 PM Evofem Biosciences Q4 Loss/share $0.50 Vs. Loss $0.27 Year Ago
12/17/2020 7:43:25 AM Evofem Biosciences Updates On Pivotal Phase 3 Trial Of EVO100 For Prevention Of Chlamydia And Gonorrhea
10/20/2020 8:12:42 AM Evofem Says First Patient Enrolled In Pivotal Phase 3 Trial Of EVO100 For Prevention Of Chlamydia And Gonorrhea
10/15/2020 8:03:19 AM Evofem Biosciences Sells $25 Mln Of Unsecured Convertible Promissory Notes To Funds Affiliated With Adjuvant Capital, LP
9/8/2020 8:35:58 AM Evofem Biosciences Announces U.S. Commercial Launch Of Phexxi On-Demand Prescription Contraceptive Vaginal Gel
8/4/2020 8:11:15 AM Evofem Q2 Loss Attributable To Stockholders $52.7 Mln Or $0.91/Shr Vs Loss Of $35.5 Mln Or $0.97/Shr Last Year
7/1/2020 8:21:05 AM Evofem Biosciences Issues Letter To Stockholders; Says Commercial Launch Of Phexxi Is On-Track For September
6/2/2020 11:29:53 PM Evofem Announces Pricing Of 28.5 Mln Shares At $3.50/Shr
6/2/2020 4:02:18 PM Evofem Announces Proposed Public Offering Of Common Stock
5/21/2020 4:06:18 PM PDL BioPharma Completes Distribution Of Evofem Biosciences Common Stock To PDL Stockholders